Alan B. Lancz & Associates, Inc. Medtronic PLC Transaction History
Alan B. Lancz & Associates, Inc.
- $98.1 Million
- Q2 2025
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Medtronic PLC stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 9,908 shares of MDT stock, worth $950,375. This represents 0.88% of its overall portfolio holdings.
Number of Shares
9,908
Previous 9,908
-0.0%
Holding current value
$950,375
Previous $890,000
3.03%
% of portfolio
0.88%
Previous 0.96%
Shares
10 transactions
Others Institutions Holding MDT
# of Institutions
2,475Shares Held
1.07BCall Options Held
10.9MPut Options Held
9.19M-
Vanguard Group Inc Valley Forge, PA127MShares$12.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY112MShares$10.7 Billion0.2% of portfolio
-
State Street Corp Boston, MA59.8MShares$5.74 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY37.6MShares$3.61 Billion0.27% of portfolio
-
Capital Research Global Investors Los Angeles, CA36.4MShares$3.49 Billion0.66% of portfolio
About Medtronic plc
- Ticker MDT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,329,149,952
- Market Cap $127B
- Description
- Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...